BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28488086)

  • 21. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
    J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
    Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
    Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of pathologic characteristics and prognosis in different subtypes of adult medulloblastoma].
    Zhao F; Zhang J; Wang X; Wang Z; Wang Y; Qu P; Luo L; Liu P
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):169-72. PubMed ID: 24842015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
    Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
    Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
    J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
    J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
    Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
    Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
    Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
    Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma.
    Zhang R; Zhou L
    Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma.
    Call JA; Naik M; Rodriguez FJ; Giannini C; Wu W; Buckner JC; Parney IF; Laack NN
    Am J Clin Oncol; 2014 Feb; 37(1):1-7. PubMed ID: 23111362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.
    Esbenshade AJ; Kocak M; Hershon L; Rousseau P; Decarie JC; Shaw S; Burger P; Friedman HS; Gajjar A; Moghrabi A
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28000417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medulloblastoma--a retrospective analysis.
    Awasthy BS; Das Gupta C; Singh R; Patel AK; Julka PK
    Indian J Pediatr; 1997; 64(5):693-7. PubMed ID: 10771904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol.
    von Bueren AO; Friedrich C; von Hoff K; Kwiecien R; Müller K; Pietsch T; Warmuth-Metz M; Hau P; Benesch M; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2015 Nov; 51(16):2434-43. PubMed ID: 26254812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
    J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
    Franceschi E; Bartolotti M; Paccapelo A; Marucci G; Agati R; Volpin L; Danieli D; Ghimenton C; Gardiman MP; Sturiale C; Poggi R; Mascarin M; Balestrini D; Masotto B; Brandes AA
    J Neurooncol; 2016 Jun; 128(2):235-40. PubMed ID: 26940908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
    Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
    Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
    Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
    J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
    Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO).
    Esbah O; Demirci U; Dane F; Gunaydsin Y; Ozdemir N; Siyar Ekinci A; Kodaz H; Yazilitas D; Rzayev R; Guney Y; Seker M; Uysal M; Inal A; Bilici A; Benekli M; Oksuzoglu B; Buyukberber S
    J BUON; 2016; 21(2):456-60. PubMed ID: 27273958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.